期刊文献+

Cyclin D1和hMSH2在结直肠癌组织中的表达及其意义 被引量:2

Expressions of Cyclin D1 and hMSH2 in Colorectal Cancer and its Pathological Characteristics
原文传递
导出
摘要 目的探讨Cyclin D1和hMSH2在结直肠癌组织中的表达及其与结直肠癌临床病理特征之间的关系。方法用免疫组化SP法检测50例结直肠癌组织中Cyclin D1和hMSH2的表达,用Kaplan-Meier法分析Cyclin D1和hMSH2的表达与临床病理特征和预后的相关性。用多因素COX模型分析影响患者预后的相关因素。结果在正常组织、癌旁组织和癌组织中Cyclin D1蛋白表达阳性率分别为0、40%和64%,而hMSH2蛋白表达阳性率分别为10%、52%和86%。在结直肠癌组织中Cyclin D1和hMSH2蛋白表达率明显高于正常组织,差异有统计学意义(P<0.01)。Cyclin D1和hMSH2在结直肠癌中表达与分期和分化程度及2年内复发率有关,差异有统计学意义(P<0.05),而与病理类型无关。多因素分析显示,Cyclin D1和hMSH2(RR值分别为2.405和2.312,P<0.05)的表达是结直肠癌的重要预后因素。结论 Cyclin D1和hMSH2基因突变可能与结直肠癌的发生、发展和预后有一定关系。 Objectlve To study the expression of Cyclin Dland hMSH2 in colorectal cancer and their relationship with the elinieopathologieal features of the disease. Methods The expression of Cyelin D1 and hMSH2 were observed in 50 cases of eoloreetal cancer tissues using immunohistochemical staining. Kaplan-Meier survival analysis was used to analyze the correlation of the expression of Cyclin D1 with the clinieopathologic parameters and prognosis of colorectal cancer. Multiple COX proportional hazards model analysis was used to analyze the prognostic factors. Results The positive rates of Cyelin D1 protein expression in normal tissue, paraeaneer organizations and cancer organizations were 0, 40% and 64%, respectively, and the positive rates of hMSH2 protein expression were 10%, 52% and 86%. The positive expression of them were related with cellular differentiation, TNM stage and the recurrence rate in two years, but it was not related with the pathological type. Multiple analyses showed that Cyclin D1 and hMSH2 expression was important prognostic factors for coloreetal cancer. Conclusion Cyelin D1 and hMSH2 gene mutations may he associated with the occurrence, development and prognosis of colorectal cancer.
出处 《中国慢性病预防与控制》 CAS 2012年第6期675-677,共3页 Chinese Journal of Prevention and Control of Chronic Diseases
关键词 结直肠癌 细胞周期蛋白 HMSH2 免疫组织化学 Colorectal cancer Cyclin D hMSH2 Immunohistoehemistry
  • 相关文献

参考文献5

二级参考文献91

  • 1杨剑锋,陈森林,刘志红,张芸.乳腺癌组织中E-cadherin、β-catenin及cyclin D1表达的相关性研究[J].癌症,2004,23(7):799-802. 被引量:23
  • 2金黑鹰,颜宏利,宋立华,崔龙,丁义江,孙树汉.中国人HNPCC家系中hMSH2基因新突变及其功能分析[J].第二军医大学学报,2005,26(8):888-891. 被引量:6
  • 3[22]Lamberti C,Kruse R,Ruelfs C,Caspari R,Wang Y,Jungck M,Mathiak M,Malayeri HR,Friedl W,Sauerbruch T,Propping P.Microsatellite instability-a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer:a study in different groups of patients with colorectal cancer.Gut 1999; 44:839-843
  • 4[23]Hendriks YM,de Jong AE,Morreau H,Tops CM,Vasen HF,Wijnen JT,Breuning MH,Brocker-Vriends AH.Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma):a guide for clinicians.CA Cancer J Clin 2006; 56:213-225
  • 5[24]Jun Wang,MH Luo.Registry and genetic research of Hereditary Colorectal Tumors.Zhongliu Fangzhi Zazhi 2002; 9:52-53
  • 6[25]Mecklin JP,Jarvinen HJ,Hakkiluoto A,Hallikas H,Hiltunen KM,Harkonen N,Kellokumpu I,Laitinen S,Ovaska T,Tulikoura J.Frequency of hereditary nonpolyposis colorectal cancer.A prospective multicenter study in Finland.Dis Colon Rectum 1995; 38:588-593
  • 7[26]Evans DG,Walsh S,Jeacock J,Robinson C,Hadfield L,Davies DR,Kingston R.Incidence of hereditary nonpolyposis colorectal cancer in a population-based study of 1137 consecutive cases of colorectal cancer.Br J Surg 1997; 84:1281-1285
  • 8[27]Ponz de Leon M,Sassatelli R,Benatti P,Roncucci L.Identification of hereditary nonpolyposis colorectal cancer in the general population.The 6-year experience of a populationbased registry.Cancer 1993; 71:3493-3501
  • 9[28]Cornaggia M,Tibiletti MG,Albarello L,Taborelli M,Dalla Longa E,Capella C.Low incidence of hereditary nonpolyposis colorectal cancer syndrome in a selected area of the Lombardy Cancer Registry.Tumori 2000; 86:439-444
  • 10[29]Katballe N,Christensen M,Wikman FP,Orntoft TF,Laurberg S.Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients.Gut 2002; 50:43-51

共引文献18

同被引文献26

  • 1Zhang R, Qin W, Xu GL, et al. A meta--analysis of the prevalence of somatic mutations in the hMLH1 and hMSH2 genes in colorec- tal cancer[J]. Colorectal Dis, 2012, 14(3):e80-89.
  • 2Friedrichs K, Gluba S, Eidtmann H, et al. Over expression of p53 and prognosis in breast cancer[J]. Cancer, 1993, 72(12):3641--3647.
  • 3Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary non polyposis colon cancer[J]. Cell,1993, 75(5):1027-1038.
  • 4Gammie AE, Erdeniz N, Beaver J, et al. Functional characterization of pathogenic human MSH2 missense mutations in saccharomyces cerevisiae[J]. Genetics, 2007, 177(2):707-721.
  • 5Sidelnikov E, Bostick RM, Flanders WD, et ai. Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms[J]. Cancer Epidemiol Biomarkers Prey, 2009, 18(11): 2965--2973.
  • 6Seifert M, Reichrath J. The role of the human DNA mismatch re- pair gene hMSH2 in DNA repair, cell cycle control and apoptosis: implications for pathogenesis, progression and therapy of cancer[J]. J Mol Histol, 2006, 37( 5--7):301-307.
  • 7Gu M, Bae YK, Kim AR, et al. Expression of hMLH1, hMSH2 and hMSH6 in small intestinal carcinomas[J].Hepatogastroenterology, 2012, 59(119): 2228--2232.
  • 8Alkhalidi H, Kfoury H. Status of mismatch repair genes hMSH2 and hMSH6 in colorectal cancer in Saudi patients: an immunohisto- chemical analysis[J]. East Mediterr Health J, 2012, 18(11):1114-1117.
  • 9Koessler T, Azzato EM, Perkins B, et al. Gommon germ line variation in mismatch repair genes and survival after a diagnosis of colorectal cancer[J]. IntJ Gancer, 2009, 124(8):1887-1891.
  • 10刘耀煌,方向明,方志军.细胞周期蛋白D1基因多态性与胃癌易感性的分析[J].检验医学与临床,2009,6(24):2117-2119. 被引量:3

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部